Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection

ClinicalTrials.gov ID: NCT03788434

Public ClinicalTrials.gov record NCT03788434. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 8:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection

Study identification

NCT ID
NCT03788434
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vedanta Biosciences, Inc.
Industry
Enrollment
79 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 7, 2019
Primary completion
Jun 1, 2021
Completion
Sep 14, 2021
Last update posted
Jul 2, 2023

2019 – 2021

United States locations

U.S. sites
29
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Phoenix Clinical, LLC Phoenix Arizona 85014
Mayo Clinic, Clinical Studies Unit Phoenix Arizona 85054
NEA Baptist Clinic Jonesboro Arkansas 72401
Alliance Research Institute Canoga Park California 91304
University of California, Davis Medical Center Sacramento California 95817
Ventura Clinical Trials Ventura California 93003
Medical Research Center of Connecticut, LLC Hamden Connecticut 06518
Innovative Research of West Florida Clearwater Florida 33756
Gastro Florida Clearwater Florida 33765
University of Florida Gainesville Florida 32610
Guardian Angel Research Center Tampa Florida 33614
Anne Arundel Health System Research Insitute Annapolis Maryland 21401
Tufts Medical Center Boston Massachusetts 02111
Massachusetts General Hospital Boston Massachusetts 02114
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Covenant HealthCare Saginaw Michigan 48604
Mayo Clinic Rochester Minnesota 55906
New York University Langone Medical Center New York New York 10016
Clinical Research of Gastonia Gastonia North Carolina 28054
Southeastern Research Center Winston-Salem North Carolina 27103
Toledo Institute of Clinical Research Inc Toledo Ohio 43617
TruCare Internal Medicine and Infectious Diseases DuBois Pennsylvania 15801
Frontier Clinical Research, LLC Uniontown Pennsylvania 15401
Advanced Clinical Research-Be Well MD Cedar Park Texas 78613
Texas Centers for Infectious Disease Associates Fort Worth Texas 76104
Clinrx Research Joseph INC Plano Texas 75007
Infectious Disease Associates of Central Virginia Infectious Disease Lynchburg Virginia 24501
Seattle Infectious Disease Clinic Seattle Washington 98101
Advanced Clinical Research-Spokane Gastroenterology Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03788434, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2023 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03788434 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →